Molecular Med Tri-Con 2011 Features GenomeQuest Panel Session on Whole-Genome Diagnostics and Emerging Significance to Health Care Industry
Panel Moderated by Author of “The $1,000 Genome”; Insight from Medical, Research, and Technology Experts; Demonstration of New Whole-Genome Diagnosis Reporting
Location: Molecular Medicine Tri-Con, Moscone North Convention Center, San Francisco, CA
When: Thursday, February 24, 3:20 pm – 3:50 pm
Background:
Whole-genome sequencing applied to diagnostics holds great promise for health care. Globally, the world spends about $5T on health care and about 65% of therapy decisions are based on the results of diagnostics tests.
With the precipitous fall in the cost of sequencing, whole-genome sequencing may soon become practical – even common – for reporting on patient susceptibility, diagnosis, and treatment of genetic disorders. Benefits of this advance to medical professionals and patients include: higher precision, ability to detect complex/multi-gene conditions, far lower long-term costs for patient, economies of scale for instrument manufacturers, higher quality/repeatability for laboratories, and faster delivery/approval of research discoveries.
Included in this panel discussion is a demonstration of a newly released capability to analyze/report on a patient’s disease susceptibility, diagnosis, and treatment on over 2000 disorders from a single whole-genome sequence.
Topics and questions addressed by this panel:
- What are recent research and technological advances in this area?
- What are real examples of benefits to patient care?
- How will this start and expand? What timeframe?
- Will this cause market disruption to the health care industry and if so, how?
- What does this mean for researchers and diagnostic companies? for regulators?
Panel Participants:
- Kevin Davies, Ph.D., editor-in-chief of BioIT World and author of “The $1,000 Genome”
- Jeffrey Saffitz, MD, Pathology Chief, Beth Israel Deaconess Medical Center
- Roberta A Pagon (invited), MD, Professor, University of Washington, Children’s Hospital & Regional Medical Center and Editor-in-Chief, GeneReviews (hosted by NCBI)
- Richard Resnick, CEO, GenomeQuest, Inc.
Video: video available for replay at www.genomequest.com/videos/molecular-med-tri-con-2011/
###
Contact: Anthony Flynn, +1 215-222-6110
